Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Nornickel's production performance continued to decline

7/29/24 GMKN

Lenta reported an increase in performance

7/29/24 LENT

Lenta reported for 6 months of 2024 by IFRS

7/29/24 LENT

Rosseti South reported for 6 months of 2024 by RAS

7/29/24 MRKY

Rosseti Urals reported for 6 months of 2024 by RAS

7/29/24 MRKU

Artgen reported for 6 months of 2024 by RAS

7/29/24 ABIO

Seligdar completed field work at the Chulkovskaya area

7/29/24 SELG

Alrosa started drilling freezing wells at the Mir-Gluboky mine

7/29/24 ALRS

DZRD reported for 6 months of 2024 by RAS

7/29/24 DZRD

DEK reported for 6 months of 2024 by RAS

7/29/24 DVEC